Speaker:

Okay, I've got one of the first questions. With no gap, who determines what

Speaker:

prosthesis is used and can the

Speaker:

surgeons choose their preferred devices determined by patient uniqueness,

Speaker:

or is the fund dictating what devices we use?

Speaker:

I guess it's the idea of managed care.

Speaker:

The fund doesn't dictate anything is the bottom line.

Speaker:

Actually, one caveat, with HCF, they

Speaker:

do dictate the type of rehab that's provided

Speaker:

so they want the patient to

Speaker:

really lock into that sort of eras

Speaker:

model of care where they spend a

Speaker:

short time in hospital and then do their rehab from home so they want patients

Speaker:

to go home within like two or three days or whatever and then they send a physio

Speaker:

out to them um that's the only real thing i think that everything else is there's

Speaker:

no there's no caveat there's no

Speaker:

there's absolutely no constraint no constraint the surgeon can choose the implants

Speaker:

that they want to do the approach there's no there's not a managed care model

Speaker:

that's in the United States and to be honest if there was I probably wouldn't

Speaker:

participate we wouldn't do it yeah

Speaker:

I think that's an important consideration for us as surgeons for that reason

Speaker:

I don't participate in HCF because I think all patients should have equal access

Speaker:

to care not based on their comorbidities dictate where they go post-operatively.

Speaker:

Got a question at the top?

Speaker:

Yep. My name is Dr. Ben Tettua from Hornsby.

Speaker:

I have a patient and a friend actually who had multiple total hip replacement

Speaker:

and multiple revisions and still have a lot of pain.

Speaker:

How would you advise or manage those difficult? post-revision pains.

Speaker:

Tony? I think that's an answer for all of us.

Speaker:

Well, I do depend on the hip surgeon's assessment as well, that there is no

Speaker:

other periprosthetic fracture,

Speaker:

that the diagnosis was the right indication for the surgery,

Speaker:

what were the expectations that the surgery was supposed to deliver,

Speaker:

so perhaps they have multifactorial problems and the hip surgery was successful.

Speaker:

It helped a particular issue like their function, their range or something,

Speaker:

but it wasn't supposed to address their pain issue.

Speaker:

The hip surgeon might think the pain issue was due to another issue that wasn't

Speaker:

going to be relieved by the surgery.

Speaker:

So having that understanding is very important.

Speaker:

So sometimes patients have a very simplistic view of what surgery is supposed to fix.

Speaker:

Every issue that they present with and it's actually multifactorial and to get

Speaker:

a better understanding of what the surgery was intended, and what they did is important.

Speaker:

The active participation of patients and their self-efficacy can't be under

Speaker:

under emphasized actually.

Speaker:

So that is the core basis of managing chronic pain is getting patients to improve

Speaker:

their self-confidence and being able to understand their symptoms, their limitations,

Speaker:

and adapting to their new experience.

Speaker:

So I do try to exclude that there is another causative factor,

Speaker:

whether that's reversible.

Speaker:

And then I'd look at things like whether they're very sensitized.

Speaker:

And if they are sensitized, I use other medications.

Speaker:

Duloxetine has not been shown to be that beneficial for arthritis per se.

Speaker:

And has been useful in somewhat for other type of arthritic conditions, particularly the knee,

Speaker:

but that might be a useful option, other adjuvant analgesia is an option and

Speaker:

looking at whether there's other procedures.

Speaker:

From a procedural point of view from a pain specialist there's not many options

Speaker:

for if it's intra-articular hip.

Speaker:

We use fascia iliaca blocks intraoperatively but there's not much of a role

Speaker:

in the chronic paste section and I agree hyaluronic acid and other regenerative

Speaker:

approaches have not been shown to be successful for hip approaches.

Speaker:

Gluteal issues, that might be something worth exploring.

Speaker:

From a pain perspective of their sensitization, we use pulse treatments there.

Speaker:

We look at whether there's a contributor from the SIJ joint or particularly

Speaker:

the lumbar facet joint, L4, L5, seems to have a referred pattern to that hip.

Speaker:

So looking for other contributors is a key component of our looking at what

Speaker:

we could do about that. So yeah, thank you.

Speaker:

Got a couple of questions online, Anthony, so it might continue with you.

Speaker:

How long can the lignocaine infusion continue to reduce pain?

Speaker:

Yes, I do have to preface that there's a lot of surgeries that are going on

Speaker:

and a lot of conditions, and ibidocaine is not,

Speaker:

apart from neuropathic pain and some surgeries, There's not a lot of robust

Speaker:

information that it's all that helpful in many surgical circumstances.

Speaker:

So I have to say that.

Speaker:

Most of the lidocaine protocols are just intraoperatively, like with the bolus

Speaker:

and intraoperative use, rather than the post-surgical use.

Speaker:

It's very uncommon to use lidocaine, except when there's a lot of nerve structures

Speaker:

being involved, are being distracted, that we would use it in the post-operative

Speaker:

setting. So it's usually interoperative use.

Speaker:

Michael, if we go just a bit to the previous question, from our point of view

Speaker:

as orthopedic surgeons, if we've got a patient with a painful joint replacement,

Speaker:

in order to treat that, we need to understand where the pain's coming from.

Speaker:

So, you mentioned that the patient has had a number of revisions.

Speaker:

We would only do a revision if we know the reason why we're doing the revision.

Speaker:

Pain is not a reason for revision.

Speaker:

Pain is a symptom. We need to find a diagnosis, what's responsible for the patient's symptoms.

Speaker:

If we don't have that diagnosis, no matter how many revisions we do,

Speaker:

we'll get the same result.

Speaker:

Whether that's infection, implant loosening, implant malpositioning,

Speaker:

whatever it might be, we need to have a diagnosis in order to treat a painful joint replacement.

Speaker:

So Anthony, just on that, if you've got a patient in the community who's been

Speaker:

lettered back to the GP saying all is good with the hip replacement,

Speaker:

if the patient's still got pain,

Speaker:

should they come to you for an assessment first, Anthony, or should they be

Speaker:

sent for a second opinion with another surgeon?

Speaker:

How do you see your role and when do you come into play?

Speaker:

I do think that most patients benefit from seeing their hip surgeon,

Speaker:

not just because that there could be issues with their hip surgery,

Speaker:

but also to get that reassurance from the surgeon who put a lot of investment

Speaker:

in that patient and the patient has invested in a relationship with their surgeon

Speaker:

and getting that reassurance from them because in terms of their prognosis,

Speaker:

being able to be reassured that their pain issue is not due to the surgery or is very important.

Speaker:

And they might not agree, but

Speaker:

that needs to

Speaker:

be explored because a key component of

Speaker:

chronic pain is to see whether pain is

Speaker:

a symptom of harm or whether its pain is just a slow recovery or they're just

Speaker:

very sensitized and they need a bit more movement and exercise and other treatments

Speaker:

that they can manage their pain and improve their optimization of their functional outcomes.

Speaker:

And just, Mike, about your question about referring for a second opinion.

Speaker:

So, you know, Tony's talked about it a lot.

Speaker:

Chronic pain, multifactorial. There's so many different things that could,

Speaker:

you know, feed into that.

Speaker:

If you're going to put that patient in on the radar of another surgeon,

Speaker:

you know, we're equipped to deal with surgical problems, right?

Speaker:

So we're equipped to deal with mechanical issues, alignment issues, all of these things.

Speaker:

So if you think there's a problem like that, that, you know,

Speaker:

the first surgeon's missed or you feel that that's probably the diagnosis,

Speaker:

then yeah, sure, second opinion.

Speaker:

But if you think that it's a chronic pain issue and there's probably more likely

Speaker:

to be all of these other complex factors that are feeding into this issue,

Speaker:

that's probably not a wise thing to do because you're putting them,

Speaker:

like I said, in that zone of influence.

Speaker:

And then the surgeons really like, what do they do?

Speaker:

I mean, they do surgeries, right? That's probably one of the last things that

Speaker:

patient may need, right?

Speaker:

So I'm not sure if a second opinion is the first thing I'll do.

Speaker:

I'd probably more refer back to the original surgeon and

Speaker:

and obviously think about you know more broader referral patterns

Speaker:

and i do this just based on someone who sees them like how often do you see

Speaker:

the second opinions or someone who comes in and then you know that that patient's

Speaker:

much more complex and there's very little that i can do to help you know apart

Speaker:

from maybe just giving them more reassurance or further tests or something just

Speaker:

to confirm what we already know that there's no.

Speaker:

There's no significant sort of biomechanical or mechanical issue.

Speaker:

And the other thing is like if I do a joint replacement, I've got a patient

Speaker:

and I've done a joint replacement and they come, then they are dissatisfied

Speaker:

with it. Yes, I investigate it.

Speaker:

And so then if I can't find anything, then I would send the patient for a second

Speaker:

opinion to try to remove that surgeon bias.

Speaker:

Because as surgeons, we think, oh, no, we're great. We do everything that we

Speaker:

do is perfect and so on. It's not our fault.

Speaker:

So just removing yourself from that decision, allowing somebody with a fresh

Speaker:

set of eyes to look at it and assess that patient is also important.

Speaker:

It's important not only for you as a surgeon, but it's most important for the patient.

Speaker:

And providing that patient with that reassurance that, well,

Speaker:

yes, no, everything looks okay. Technically, everything has been done fine.

Speaker:

There is no reason to revise that joint.

Speaker:

So then they can explore additional treatment methods. Thank you.

Speaker:

Sorry, I've got a couple of questions. One for Dr. Coetzee.

Speaker:

A lot of surgical patients broadly, not just orthopedic patients,

Speaker:

obviously, are discharged from public hospitals, private hospitals on opioids.

Speaker:

And that obviously presents some challenges in a primary care setting or at

Speaker:

MISE in helping those patients transition.

Speaker:

So I'm wondering if you could sort of talk about that a little bit.

Speaker:

And then just the role, if any, you see cannabis-based analgesia playing,

Speaker:

given the controversy at the moment and the sort of upheaval that appears to

Speaker:

be occurring with the TGA wanting to constrain, to some extent, access to these things.

Speaker:

Then my second question for the orthopedic surgeons is really.

Speaker:

What you outlined about intra-articular steroid doesn't concur with my experience in primary care,

Speaker:

I mean obviously steroids are used broadly in various joints and I'm thinking

Speaker:

particularly maybe a younger patient who does probably merit a joint replacement

Speaker:

but is uninsured and so is looking at 12 months,

Speaker:

24 months on a public hospital waiting list.

Speaker:

I'd be interested in your thoughts in that context.

Speaker:

The bullet sticker first.

Speaker:

I'm going to be very blunt about the whole steroid in the joint issue.

Speaker:

I know Raz mentioned it, but...

Speaker:

There's definitely some data to suggest that if you've had a recent steroid

Speaker:

injection, you are at increased risk of complications, particularly infection.

Speaker:

But that is very flawed, okay? It's, you know, it's easily, if you were to just

Speaker:

read that evidence with, you know, any sort of critical appraisal approach,

Speaker:

you'll realize that it's confounded by lots and lots of things.

Speaker:

So the issue for me then is that I've got

Speaker:

this data that I now have sort of lower confidence in

Speaker:

in terms of whether this is a real thing but

Speaker:

then I've got a patient in front of me like you like you

Speaker:

sort of gave the example of that public patient who's like

Speaker:

struggling who just wants to get over the line before

Speaker:

they have their surgery I'm going to do that injection sorry

Speaker:

I'm going to do that injection I might the most

Speaker:

I'll do is I might mention it to the patient to say that there's a tiny increase

Speaker:

in you know chance that you might have the infection is it worth it for you

Speaker:

you know maybe because you do get that short-term relief just to get you over

Speaker:

the line to just improve your quality of life right so for me i.

Speaker:

I still use them um i still use them you know um i think a lot of the fear now

Speaker:

is going to be like a medico-legal one because it's become such routine accepted

Speaker:

sort of practice in our community,

Speaker:

and unfortunately you will find someone one colleague who

Speaker:

will say oh that was the wrong thing this is if something goes wrong

Speaker:

right something goes wrong they'll say that that's probably the wrong thing

Speaker:

to do even though it's based on data right so that's that's i think a probably

Speaker:

one of the main considerations for why people are now going off it but then

Speaker:

people are going to suffer right

Speaker:

people are suffering in the meantime and that's really really sad for me,

Speaker:

really sad but it's three months have you got a safe time frame if they they

Speaker:

know the surgery is not for the next three months that's safe or i think if

Speaker:

you know the problem is in a public sector you don't really know when their

Speaker:

time is going to come up as well like you know they're just given dates and I sort of rock up,

Speaker:

but private sectors a little bit more controlled.

Speaker:

Well, I think the three months, that seems to be the going time frame at the moment.

Speaker:

That's from a medical legal standpoint. The problem is what Sam said,

Speaker:

the problem is that in orthopedics it's very difficult to do high quality studies

Speaker:

to assess for just one issue,

Speaker:

like infection after corticosteroid injection in hip replacement.

Speaker:

There are so many factors that affect the risk of an infection in a patient

Speaker:

who undergoes joint replacement surgery.

Speaker:

And the data on the intra-articular corticosteroids, it comes from the knees.

Speaker:

It's been done in the knees, the studies, and they've been extrapolated to the hips.

Speaker:

In knee arthritis, yeah. But I don't use, well, the only time that I would use

Speaker:

a corticosteroid injection is at the first symptom of arthritis.

Speaker:

If that had recurrent exacerbation of arthritis, I do not find any benefit.

Speaker:

I do not use it. I don't think there is any strong evidence for use to provide.

Speaker:

What we're thinking here when we treat patients with arthritis,

Speaker:

arthritis is a long-term problem. We need to provide a treatment that provides

Speaker:

long-term pain reliefs. Well, the steroids do not.

Speaker:

So then I'm not using it. Just quickly, there's a question online and back to the first question.

Speaker:

Anthony, these patients that get dumped back to the GPs after they've had the

Speaker:

surgery, they're still in pain.

Speaker:

How many weeks before they come to see you? Have you got some recommendations

Speaker:

for the GPs regarding the opioid post-operative management?

Speaker:

Because, you know, we see a lot of GP bashing in the media. So can we give them

Speaker:

a safe pathway for what to do with the post-operative surgical patient?

Speaker:

Yeah, a few comments. My picture across the board has been more and more discussed.

Speaker:

What I'll be discussing five years ago is not the same that I'll be discussing

Speaker:

today and won't be the same in five years' time.

Speaker:

So it's an open space on how we can help patients use opioids wisely.

Speaker:

Function is important so getting them

Speaker:

to move using opioids appropriately we want them

Speaker:

to use opioids to to mobilize early because

Speaker:

that does improve all their outcomes so we have no

Speaker:

problems with that I it's true

Speaker:

that the issues of using opioids particularly after the first or two weeks that

Speaker:

is an issue some hospitals would have sub acute pain services for early referrals

Speaker:

patients that have been shown to be a higher risk because of those risk factors

Speaker:

that I've discussed before, female, younger.

Speaker:

A lot of anxiety issues or catastrophizing behaviors, for instance,

Speaker:

and some that is a bit of screening in postoperatively to try to get those patients

Speaker:

into those subacute units.

Speaker:

In the private space, particularly here, yes, I'm happy to see those type of

Speaker:

patients in the postoperative period.

Speaker:

Some of us pain specialists have less waiting periods and can be able to see

Speaker:

and accommodate these patients fairly quickly.

Speaker:

We'd like to see before they become a significant use.

Speaker:

One of their issues is that a lot of patients that come to see us,

Speaker:

they have a psychological distress and issues that are very difficult to just help in a very short,

Speaker:

time-limited way when you are not remunerated quite well for these short consultations

Speaker:

and trying to give them that education,

Speaker:

self-empowerment, improve their self-confidence, and trying to manage their

Speaker:

expectations and their opioid use more successfully.

Speaker:

And we have sometimes the language and expertise to be able to reach out to

Speaker:

even the more difficult patients that you routinely see,

Speaker:

because you probably do this successfully a lot of the times, eight out of 10 times.

Speaker:

It's just those few patients that you do think are going to be struggling with.

Speaker:

And also you want to keep that relationship with the patient and have that opioid

Speaker:

stewardship stuff happen with someone else that they might not have a longitudinal

Speaker:

relationship, we're happy to see and get referral early on, no problems at all.

Speaker:

The role of cannabis? Cannabis. My college has come out against the use of medicinal

Speaker:

cannabis due to just the lack of data.

Speaker:

So a lot of data is still unknown.

Speaker:

It seems to be more helpful for neuropathic pain, but even then the number needed

Speaker:

to treat is pretty high, around 15 to 20, which is higher than what we use for anything else.

Speaker:

So duloxetine is about 6 to 7, Pugabin 4, Tramadol 4, so it's and the number

Speaker:

needed to harm is also quite significant for all cannabinoids.

Speaker:

So the other way is how do we use it, also is another factor, how do we try to treat it.

Speaker:

There are more and more guidelines to use it. I

Speaker:

use in the palliative care space a lot for nausea vomiting and

Speaker:

appetite even then i'm not being

Speaker:

greatly impressed by the results uh from a

Speaker:

from my point of view um and the

Speaker:

uh so and the space is not that it's it's

Speaker:

coming more regulated but it's uh there's still uh there's

Speaker:

a lot of cowboy um stuff that's happening in that space too uh so uh cannabinoids

Speaker:

might have a place uh but i don't it's not definitely not a panacea and definitely

Speaker:

it's not defined compared to the conventional ways that we manage pain issues.

Speaker:

So that is just my two cents about cannabinoids.

Speaker:

I'm sorry this is actually a knee question but it is related to pain.

Speaker:

I've got a patient at the moment, lovely gentleman, used to have a very physical

Speaker:

job as a gardener and then did through workers comp get both knees bilateral knee replacements.

Speaker:

One knee going pretty well, the other knee or leg, constant pain,

Speaker:

rubbing, it's tight etc and not a man prone to exaggeration.

Speaker:

So you get concerned when the wife comes in to one of the consultations to make

Speaker:

sure that he's telling you that the pain is limiting his life.

Speaker:

He's also not happy with his orthopedic surgeon, no one here,

Speaker:

and has lost confidence, and I have become the go-to girl.

Speaker:

So what I have done is tried to come at it laterally.

Speaker:

I've called in the wonderful physios at MQ Health, and we had a conference because

Speaker:

my brain was, you know, getting overloaded. Where do we go next?

Speaker:

Alex and I workshopped some ideas. It made the patient feel listened to because

Speaker:

he hadn't felt listened to.

Speaker:

I had gone ahead and ordered an MRI of the knee in somewhat desperation.

Speaker:

Alex, the physio, did say he was an ex-smoker. Have you thought of doing Dopplers

Speaker:

just to make sure it's not arterial?

Speaker:

Turned out okay. because there was lots of bits and things on the MRI.

Speaker:

There was a larger fusion. There was a possible small ganglion.

Speaker:

I was on the edge of giving him pain relief options such as Cymbalta,

Speaker:

but then I saw stuff on the MRI.

Speaker:

Did I do the right thing? The physio said sometimes just doing plain x-rays

Speaker:

just to show the position of the implants is probably the better thing to do.

Speaker:

But now it's so hard to know which way is up and which way is down with this patient.

Speaker:

I have asked him just to go back to his surgeon to look at it,

Speaker:

But it is really hard from all these discussions to know when we go,

Speaker:

the more go back to your surgeon route versus when do I start duoxetine or CBT

Speaker:

or perhaps even ask one of your good selves to a conference with myself and

Speaker:

the physio. Do you do that?

Speaker:

So can I answer that? So knees are very different to hips as we've discovered.

Speaker:

So sorry I don't know the gentleman's name at the back but the story that you gave about your,

Speaker:

friend having repeat surgeries and being unhappy is

Speaker:

actually a rare story in hips okay in knees it's quite common okay knees you

Speaker:

know if you look at the literature 20-25 percent are unhappy with their knee

Speaker:

for one reason or another and a lot of those then get that chronic post-surgical pain In fact,

Speaker:

in Australia, we've got good data. It's about 10%.

Speaker:

Who have that chronic post-surgical pain, which is a large number when you think

Speaker:

about, what, 70,000 knee replacements a year?

Speaker:

So 10% of those potentially having that persistent pain down the track.

Speaker:

So the thing with knees is, thank you for looking after that patient,

Speaker:

right? You seem like you're doing all of the right things.

Speaker:

The thing is with knees is, you know, chronic post-surgical pain is quite complex.

Speaker:

It's not always those mechanical and loosening issues, right?

Speaker:

So sure, the surgeon is well-equipped to deal with that aspect of things.

Speaker:

Are we well-equipped to deal with chronic pain issues, neuropathic pain, psychological issues?

Speaker:

Absolutely not. We are hopeless at doing that sort of stuff.

Speaker:

And we don't have a good model of care to deal with that situation.

Speaker:

Like if you're seeing me, even me knowing about this stuff, because this is

Speaker:

a very much an academic interest of mine.

Speaker:

I'm not very well equipped to do it, so basically the best I can do is do my

Speaker:

bit. My bit is sort of examining the mechanics and alignment and making sure

Speaker:

that everything's good from a surgical point of view, exclude infection, etc.

Speaker:

But then I have to have a team around me. So the reason why I'm saying all of

Speaker:

those things is we're actually developing a model of care right now.

Speaker:

This is one of the big things that's taking up a lot of my time.

Speaker:

The project is called EPIC Early Pain Intervention and Knee Replacement,

Speaker:

you're not alone so it's got massive interest in

Speaker:

fact everyone was interested and they just threw it

Speaker:

we've got like 4 million dollars or something in grant

Speaker:

funding just to do this study and basically what we're doing is we're developing

Speaker:

this model of care that's led by this sort of clinician that's going to sort

Speaker:

of take them through and ask them about all of these potential problems that

Speaker:

they could be facing and then sort of tailoring a program for them and then

Speaker:

following them up because a lot of it is, as you've been doing,

Speaker:

is a lot of hand-holding and TLC and this is okay and listening and all of those

Speaker:

things to make sure that they're on the right track,

Speaker:

to deal with their problem.

Speaker:

I think in this patient's case, it's not sort of six months or a year.

Speaker:

It's sort of three to four years down the track. And I think it's just got into

Speaker:

a too hard basket for the surgeon, I think. Yeah.

Speaker:

And, yeah, do you ever do a conference as surgeons with the GPs and the physios

Speaker:

in a case like this? I have, yeah. Yeah.

Speaker:

Uncommonly, but I have. Sandra, I'm sorry. I'm going to have to call time.

Speaker:

We do need to go to morning tea. So if everybody can please thank our lovely

Speaker:

speakers for this morning and you can catch them over morning tea.